Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Attie

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiencyE O Reiter, K M Attie, T Moshang, et al.
The New England Journal of Medicine|November 10, 1983
Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent)D Glover, L Riley, K Carmichael, et al.
Orthopedics|July 1, 1989
Quantitative computed tomography reflects vertebral fracture morbidity in osteopenic patientsF S Kaplan, M Dalinka, J S Karp, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1978
A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin DS J Marx, A M Spiegel, E M Brown, et al.
The New England Journal of Medicine|October 26, 1995
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study GroupA D Goddard, R Covello, S M Luoh, et al.
Therapeutic Advances in Hematology|December 12, 2022
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemiaAntonio Piga, Filomena Longo, Maria Rita Gamberini, et al.
Muscle & Nerve|July 28, 2016
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trialCraig Campbell, Hugh J McMillan, Jean K Mah, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2005
Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiencyAndrew R Hoffman, Beverly M K Biller, David Cook, et al.
Nature Medicine|March 2, 2026
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trialSteven B Heymsfield, Louis J Aronne, Penelope Montgomery, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidismE M Brown, A E Broadus, M F Brennan, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Endocrinology and Metabolism|October 16, 2001
A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiencyE O Reiter, K M Attie, T Moshang, et al.
The New England Journal of Medicine|November 10, 1983
Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent)D Glover, L Riley, K Carmichael, et al.
Orthopedics|July 1, 1989
Quantitative computed tomography reflects vertebral fracture morbidity in osteopenic patientsF S Kaplan, M Dalinka, J S Karp, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1978
A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin DS J Marx, A M Spiegel, E M Brown, et al.
The New England Journal of Medicine|October 26, 1995
Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study GroupA D Goddard, R Covello, S M Luoh, et al.
Therapeutic Advances in Hematology|December 12, 2022
Long-term safety and erythroid response with luspatercept treatment in patients with β-thalassemiaAntonio Piga, Filomena Longo, Maria Rita Gamberini, et al.
Muscle & Nerve|July 28, 2016
Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trialCraig Campbell, Hugh J McMillan, Jean K Mah, et al.
The Journal of Clinical Endocrinology and Metabolism|September 15, 2005
Efficacy of a long-acting growth hormone (GH) preparation in patients with adult GH deficiencyAndrew R Hoffman, Beverly M K Biller, David Cook, et al.
Nature Medicine|March 2, 2026
Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trialSteven B Heymsfield, Louis J Aronne, Penelope Montgomery, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1979
Direct comparison in vivo and in vitro of suppressibility of parathyroid function by calcium in primary hyperparathyroidismE M Brown, A E Broadus, M F Brennan, et al.
Pageof 7